Objective: To analyze the value of C-arm CT and angiography in the diagnosis of liver cancer and the value of interventional therapy. Methods: Sixty-three patients with hepatocellular carcinoma confirmed by our hospital were treated with interventional therapy. Among them, 66 patients were C-arm CT-assisted interventional therapy group, CT group, 70 patients in DSA-assisted intervention group and DSA group. The Methods for the diagnosis of tumor blood supply and the effect of adjuvant intervention were compared. SPSS 17.0 statistical software was used to build the database and complete the data analysis. Results: In the study, CT images of the patients with both CT and DSA imaging results suggest that the location of the main lesion consistent with that of DSA, the number and size were basically matching. In the CT group, 61 patients(92.42%) had arterial blood supply, 5(7.58%) and moderate blood supply. The DSA group indicated that 60 cases(85.71%) showed arterial blood supply, 8 cases(11.43%) and 2 cases(2.86%) were moderate and less blood supply. There was no statistical difference between the two groups. At the same time, the two Methods were found to have direct blood supply of portal vein cases; CT group showed 7 cases(10.61%) cases of portal vein blood supply cases, DSA group suggested 6 cases(8.57%) portal vein blood supply cases with no differences between the two groups. The effective rate of CT group was significantly higher than that of DSA group(17.14%), P<0.05; In addition, the effective rate of CT group was 59.09%, the total effective rate was 93.94% in the study which was(effective + effective)/total number of cases×100%; DSA group effective rate was 71.43% The total effective rate was 88.57%, but the difference between the effective and the total effective rate was not statistically significant between the two groups. Conclusion: C-arm CT-assisted diagnosis and treatment of liver cancer can provide more detailed real-time image information, which has ertain contribution in improving the effective rate, thus it is worthy of clinical promotion. |
[1] 丛文铭,步宏,陈杰,等.原发性肝癌规范化病理诊断指南(2015版)[J].临床与实验病理学杂志,2015,31(3):241-246.
[2] MINAMI Y,MURAKAMI T,KITANO M,et al.Cone-beam CT angiography for hepatocellular carcinoma:Current status[J].Dig Dis,2015,33(6):759-764.
[3] 祝普利,尹超,冯建龙.原发性肝癌综合治疗进展[J].临床肝胆病杂志,2015,31(6):965-968.
[4] TOGNOLINI A,LOUIE J D,HWANG G L,et al.Utility of C-arm CT in patients with hepatocellular carcinoma undergoing transhepatic arterial chemoembolization[J].J Vasc Interv Radiol,2010,21(3):339-347.
[5] 龚杰,宋云,徐尔侃,等.肝癌的临床治疗新进展[J].肝胆胰外科杂志,2016,28(6):522-525.
[6] 敖劲,曾令雯,刘衡,等.原发性肝癌DSA表现与TACE疗效的关系分析[J].中国普通外科杂志,2016,25(1):51-56.
[7] 孙厚坦,赵威武,陈朝旻,等.门静脉超声造影对肝细胞癌血供的观察[J].中华超声影像学杂志,2015(6):547-548.
[8] GROZINGER G,KUPFERSCHLAGER J,DITTMANN H,et al.Assessment of the parenchymal blood volume by C-arm computed tomography for radioembolization dosimetry[J].Eur J Radiol.2016,85(9):1525-1531.
[9] 包中涛,李海英,叶真,等.超声造影对肝脏局灶性病变误诊分析[J].中国介入影像与治疗学,2015,12(7):428-431.
[10] 冯少阳,石彦斌.超声造影与增强CT对肝脏局灶性病变诊断的对比研究[J].海南医学,2015,26(9):1292-1294.
[11] TACHER V,RADAELLI A,LIN M,et al.How I do it:Cone-beam CT during transarterial chemoembolization for liver cancer[J].Radiology.2015,274(2):320-334.
[12] PEYNIRCIOGLU B,HIZAL M,ÇIL B,et al.Quantitative liver tumor blood volume measurements by a C-arm CT post-processing software before and after hepatic arterial embolization therapy:comparison with MDCT perfusion[J].Diagn Interv Radiol.2015,21(1):71-77.
[13] 余炎,吕君,余祖江,等.四种影像学检查评价原发性肝癌患者介入治疗的疗效[J].实用肝脏病杂志,2017,20(2):199-202.
[14] 贵传玲.超声造影技术对原发性肝癌介入治疗效果的评估价值[J].山东医药,2016,56(33):86-88.
[15] 李海峰,耿丽莉,穆永胜,等.C臂CT技术在介入治疗肝细胞癌中的应用价值[J].中国临床研究,2015,28(6):795-797. |